Quarkmed
↗Beijing, China
Quarkmed is a full-service Contract Research Organization (CRO) headquartered in Beijing, China, specializing in clinical research for innovative and generic drugs. Founded in 2011, the company has established a strong reputation for its expertise in niche and high-complexity therapeutic areas, particularly nuclear medicine (radiopharmaceuticals), oncology, cell and gene therapy (CGT), and neuropsychiatry.
The company provides end-to-end clinical development services, including clinical trial management (Phase I-IV), biostatistics, data management, medical writing, and international regulatory registration (covering North America, Europe, and Australia). Quarkmed is known for integrating artificial intelligence and digital transformation into clinical management to enhance trial efficiency and data quality.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2011
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$10M-$20M (Estimated based on 'tens of millions of RMB' Series A)
Investors:Taikun Fund (泰鲲基金), BOHE Angel Fund (薄荷天使基金), Hangzhou Capital (杭州资本), Guoshun Jianheng Fund
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 3 (Service provider for client assets)
Modalities:Small molecule, Radiopharmaceuticals, Cell therapy (CAR-T), Gene therapy, ADC
Active Trials:50
Trial Phases:Phase 1: 20 | Phase 2: 15 | Phase 3: 10 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Lindao Medical (Medical Device CRO), Heyue Medicine
Key Partnerships:Jingxin Pharmaceutical (Phase III collaboration), Coherent Biopharma (CBP-1008 trial), 3D Medicines
COMPETITION
Position:Niche Player (Leader in Nuclear Medicine CRO)
Competitors:Tigermed, WuXi AppTec, ClinChoice, Novotech
LEADERSHIP
Key Executives:
Yuan Dawei (苑大为) - Founder & CEO
Xiaochun Huang - Co-Founder / VP
Scientific Founders:Yuan Dawei
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Quarkmed. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.